VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
XERSXeris Biopharma Holdings, Inc.
$7.40$1.3B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksXERSPrice History

XERS logoXeris Biopharma Holdings, Inc. (XERS) Stock Price History

Historical prices from 2018 to 2026

$7.40+0.00  (+0.00%)close Jun 25
Returns
1M
+18.2%
3M
+39.6%
YTD
+0.7%
1Y
+57.1%
3Y
+41.5%
5Y
+9.0%
ATH$27.98Sep 2018-73.6%
ATL$0.97Jan 2023pre-split
Avg Vol (50D)1.6M/ day
52-Week Range$4.52 — $10.08
LowCurrent: $7.40High

Loading 10-year price history...

XERS Historical Performance

1 YearTotal Return
+58.8%
Price: +57.1%
3 YearsTotal Return
+183.5%
CAGR: +41.5%
Price: +183.5%
5 YearsTotal Return
+71.3%
CAGR: +11.4%
Price: +53.8%
YTD
+0.7%

XERS Annual Returns

Year-by-year price performance · 2018–2026

Best+126.9%2025
Worst-59.7%2019
Up years3/9
2018-15.9%
2019-59.7%
2020-26.6%
2021-44.8%
2022-52.7%
2023+109.8%
2024+49.3%
2025+126.9%
2026-16.7%
2018 annual price return
-15.9%
2019 annual price return
-59.7%
2020 annual price return
-26.6%
2021 annual price return
-44.8%
2022 annual price return
-52.7%
2023 annual price return
+109.8%
2024 annual price return
+49.3%
2025 annual price return
+126.9%
2026 annual price return
-16.7%
LessMore
Alpha vs S&P 500
1Y+38.0%
3Y+15.6%
5Y+1.5%

Price returns only.

Download Historical Data

2,014 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

XERS Stock Price Trajectory (2018–2026)

As of June 26, 2026, Xeris Biopharma Holdings, Inc. (XERS) trades at $7.40, representing a +57.1% return over the past year. The stock has delivered a +71.3% total return over five years (+9.0% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $27.98 on September 12, 2018. From this peak, XERS has corrected -73.6%, currently trading 5% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers LNTH (+35.3% 1Y), SUPN (+43.2% 1Y), and PAHC (+28.6% 1Y), XERS has underperformed the peer group average. Compare XERS vs LNTH →

XERS Historical Price Data · from 2018

Rows 1–50 of 2,014
Date Open High Low Close Volume Change %
2026-06-257.417.627.347.401.88M0.00%
2026-06-247.287.507.287.401.55M+2.78%
2026-06-236.947.306.937.201.93M+4.35%
2026-06-227.017.116.876.901.54M-0.72%
2026-06-187.037.066.926.951.95M+0.72%
2026-06-176.907.056.796.901.36M0.00%
2026-06-166.896.936.836.901.42M+0.29%
2026-06-156.886.886.746.881.34M+1.33%
2026-06-127.077.086.796.791.63M-2.02%
2026-06-116.687.076.616.932.95M+3.28%
2026-06-106.567.006.516.712.15M+3.23%
2026-06-096.256.546.256.501.64M+4.17%
2026-06-086.236.306.206.24827K+0.97%
2026-06-056.176.256.106.181.01M+0.49%
2026-06-045.966.175.936.151.46M+4.41%
2026-06-035.995.995.815.891.15M-1.83%
2026-06-025.966.045.876.001.35M-1.15%
2026-06-016.136.195.996.071.63M-1.46%
2026-05-296.356.366.036.161.82M-2.53%
2026-05-286.206.396.176.321.65M+1.44%
2026-05-276.276.386.166.23930K-0.48%
2026-05-266.236.286.156.26942K+1.13%
2026-05-226.386.436.126.191.05M-2.98%
2026-05-216.186.396.106.381.15M+2.41%
2026-05-205.926.255.916.231.39M+5.24%
2026-05-196.006.005.835.921.37M-1.50%
2026-05-186.256.275.966.011.33M-3.69%
2026-05-156.306.416.246.241.19M-2.04%
2026-05-146.416.466.286.371.44M-0.93%
2026-05-136.216.476.146.431.60M+2.72%
2026-05-126.146.336.106.261.73M+1.95%
2026-05-116.556.626.106.142.47M-5.97%
2026-05-086.466.586.326.532.99M-1.51%
2026-05-076.627.006.196.635.52M+4.08%
2026-05-066.296.446.166.371.92M+2.25%
2026-05-056.396.466.216.231.34M-1.74%
2026-05-046.206.406.196.34862K+0.96%
2026-05-016.176.336.106.281.38M+2.53%
2026-04-306.026.216.026.13998K+1.74%
2026-04-296.016.085.976.021.04M-1.15%
2026-04-286.096.176.016.09929K-0.49%
2026-04-276.046.176.026.12888K+1.16%
2026-04-245.986.075.896.051.00M+1.68%
2026-04-236.046.075.905.951.13M-1.49%
2026-04-225.936.065.836.041.37M+2.55%
2026-04-216.256.295.875.891.96M-5.61%
2026-04-206.316.366.186.241.45M-2.04%
2026-04-176.266.416.176.371.24M+4.08%
2026-04-166.216.276.096.121.38M-1.29%
2026-04-156.086.226.056.201.02M+2.14%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XERS — Frequently Asked Questions

Quick answers to the most common questions about buying XERS stock.

How has XERS stock performed recently?

XERS returned +57.1% over the past year, beating its 5-year annualized CAGR of +9.0%. The stock trades above its 200-day moving average, confirming the uptrend.

What is XERS's all-time high price?

Xeris Biopharma Holdings, Inc. reached $27.98 on 2018-09-12. The 52-week high is $10.08. Current 1-year return of +57.1% places the stock closer to historical peaks.

Where can I download XERS historical price data?

This page provides XERS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.

404 data points · sampled from 2,014